Insomnia after ischemic stroke
Conditions
Interventions
Control Group:Eszopiclone tablets 1 mg orally once daily before bedtime for seven consecutive days.
Treatment group:Shangxia Liangji Dan decoction, twice daily at 400 ml, for seven consecutive days.
Sponsors
Nanhu University Affiliated Nanhu Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria for cerebral infarction and insomnia in modern medicine; (2) Meets the diagnostic criteria for stroke and insomnia in traditional Chinese medicine; (3) Meets the criteria for the syndrome of insufficient communication between the heart and kidney in post-stroke insomnia; (4) Has stable and safe vital signs, with no severe diseases such as heart or liver conditions; (5) Is conscious, cooperative during physical examination, with no severe cognitive impairment or inability to cooperate; (6) Had no pathological manifestations such as insomnia before stroke, current insomnia duration =6 months, with a Pittsburgh Sleep Quality Index (PSQI) score >7; (7) Is aged between 40 and 80 years; (8) Has signed the informed consent and is able to cooperate with the treatment.
Exclusion criteria
Exclusion criteria: (1) Those who do not meet the previously described clinical case diagnostic criteria and inclusion criteria; (2) Excluding those with insomnia caused by diseases other than stroke; (3) Excluding those in pregnancy or lactation period; (4) Excluding those with allergic reactions or allergic constitution to the investigational drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Syndrome Scoring Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical Symptoms; | — |
Countries
China
Contacts
Public ContactOuyang Bo
Hunan Province, Hengyang City, Zhuhui District, South Dongfeng Road, Nan Hua University Affiliated Nan Hua Hospital
Outcome results
None listed